Upcoming Events
Log In
Pricing
Free Trial

Wk 5, Case 5 - Review

HIDE
PrevNext

0:00

This was a 42-year-old,

0:03

so she was young as well.

0:05

And, um, she had actually been wandering

0:09

around, being reassured over and over

0:11

again at the age of 42 that her palpable

0:13

mass in the right breast was fine.

0:17

Uh, which, of course, it turns out, not

0:18

to be, but there had been a much longer

0:20

program as compared to the last patient,

0:23

the 47-year-old, where there'd been

0:24

rapid enlargement of her breast mass.

0:27

This patient had not had a much slower program.

0:30

Um, had had a much slower program.

0:35

And, um, you can see why there

0:37

would be that may be difficult.

0:39

First of all, it almost

0:41

feels that it's too lateral.

0:42

It almost feels that it is literally in

0:44

the chest wall rather than in the breast.

0:47

But you can see in her right breast.

0:50

So, this is the right lower outer quadrant.

0:52

We have an enhancing mass.

0:55

She is small-breasted and this, um...

0:58

This window, I'm sorry, this

1:00

field of view is not acceptable.

1:02

I know we had a field-of-view question

1:04

a field-of-view case in week 3, but

1:07

this field of view is not acceptable.

1:09

Um, that being said, uh, it's,

1:13

um, a great example, and I'm

1:16

hesitant to use that term, but it's

1:18

true of both pectoral muscles.

1:22

And in her case, intercostal

1:24

muscle, we're going to look more.

1:26

So, at her images now, so she

1:30

has a speculated mass and it is.

1:36

So, this is her contralateral normal side.

1:39

I'm showing you that by design.

1:41

You can see quite nicely in the inferior,

1:45

um, quadrants, maintenance of normal,

1:48

uh, uh, fat and normal parenchyma and

1:52

respect for the boundaries of the chest wall.

1:55

And in contrast, Going to go through the

1:58

midline now, then we're going to come across.

2:02

This is also a really nice area to be able

2:05

to clear the internal mammary vessels as well.

2:08

Internal mammary lymph node chain.

2:11

This is the vessel and this explains

2:14

why you're able to trace it up and down and

2:16

the adjacent images and the sagittal image.

2:18

It's all laid out as the single

2:19

vessel, the internal mammary artery.

2:22

Just keep going here.

2:27

So, now we've scrolled far enough laterally

2:30

and believe me, it's very lateral.

2:32

We're barely seeing the subdermal fat of only

2:35

part of the right breast, but you can see quite

2:38

readily a speculated avidly enhancing mass.

2:43

And there is no, there's no separation

2:46

whatsoever from the thin wisp of

2:50

pectoral muscle that still exists there.

2:52

There's very little there, but the thin

2:54

wisp of pectoral muscle and certainly the

2:57

intercostal muscles, you can see the, the, the

3:00

mass actually invades almost, seemingly almost

3:03

through the entire chest wall at that point.

3:05

So certainly through the muscle.

3:07

That bore out on, um, in particular,

3:11

ultrasound as well.

3:13

It was plastered, um, plastered against the

3:15

chest wall on ultrasound, and, as importantly,

3:19

clinical exam where there was a fixed mass.

3:21

So it was fixed to the chest wall.

3:22

So all those things together, um, uh,

3:26

indicate, uh, uh, chest wall involvement.

3:29

So, uh, pectoral muscle only

3:32

is not chest wall involvement.

3:34

Uh, it requires, as in this case, an example

3:37

of intercostal muscle or transversus muscle

3:40

involvement and fixation, a fixed finding on

3:45

clinical exam, as long as the patient, um, as

3:50

long as the mass is able to be felt clinically.

3:52

This is an example of locally

3:55

advanced breast cancer.

3:56

It is in contrast to the inflammatory

3:58

breast cancer of the last patient.

4:00

These patients don't have photurange, uh,

4:03

they typically have a longer time frame.

4:05

These are not rapidly growing masses

4:08

by any stretch of the imagination.

4:09

The, uh, um, histology is typically favorable

4:14

in the sense that, um, they're often lower

4:17

grade and have been growing for a while.

4:19

But these are the two.

4:21

Locally advanced are the tumors that have

4:22

invaded the chest wall and or invaded the skin.

4:26

Um, it's also a stage three breast

4:28

cancer and a very curable stage.

4:31

Uh, locally advanced breast cancer

4:32

is even more, is, is, is, is even,

4:36

uh, much more curable, uh, typically.

4:40

Then is inflammatory cancer, both of which

4:42

are actually stage 3 tumors, and both of which

4:46

require, um, a whole-body staging. Inflammatory

4:51

cancer is far more likely to have, oh no, a

4:54

stage 4 component to it with distant metastasis.

4:58

Locally advanced breast cancer, by definition,

5:00

does not have, does not have metastasis.

5:04

They could have delayed bone metastasis,

5:06

but again, typically patients do very well.

Report

HISTORY: 42-year-old woman presenting with a palpable mass in the RLOQ sent for breast MRI at outside institution following a BIRADS 5 US. (note, this is not recommended standard of practice, we would recommend US guided biopsy before MRI).

Summary of prior imaging:

Mammography: Focal asymmetry extreme lateral right breast
Ultrasound: 1.5 cm hypoechoic spiculated mass at site of palpable mass
Breast MRI: NA

FINDINGS

Quality control issues: ☒None ☐Poor/lack contrast bolus ☐Poor fat suppression
☐Susceptibility ☐Movement ☐Other

Background Parenchymal Enhancement: Mild
Amount of Fibroglandular Tissue: Scattered fibroglandular tissue

LEFT BREAST

Narrative: Scattered foci consistent with FCD/hormonal changes. No suspicion of malignancy.

Associated findings LEFT breast: X NONE ☐Nipple retraction, ☐Nipple involvement, ☐Skin retraction, ☐Skin thickening, ☐Skin invasion-direct, ☐Skin invasion-inflammatory, ☐Pectoral muscle invasion, ☐Chest wall invasion, ☐ Architectural distortion

Non-enhancing findings LEFT breast:X NONE ☐High ductal signal pre contrast T1,
☐Cyst(s), ☐Hematoma/seroma, ☐Post therapy skin/trabecular thickening,
☐Non-enhancing mass, ☐Architectural distortion, ☐Signal void from clips

Fat containing lesions LEFT: ☐Fat necrosis, ☐Hamartoma, ☐Post-operative
seroma/hematoma with fat

Lymph nodes LEFT: ☒Normal axillary, ☐Abnormal axillary, ☐ Abnormal internal mammary

RIGHT BREAST
Narrative: 1.5 cm spiculated mass in the lateral right breast involving pectoralis and intercostal muscles. 3 cm of linear non mass enhancement extending anteriorly from this mass.

Right breast lesion 1
Lesion type: Mass
1.5 cm. Lower outer Quadrant. 8:00 Radian. 5 cm from the nipple

Mass/post-surgical change: Shape:Irregular. Margins:Not circumscribed-spiculated , Enhancement: Heterogenous. Kinetics: Cannot assess

BI-RADS:5: Highly suggestive of malignancy – Appropriate action should be taken

Right breast lesion 2
Lesion type: Non-mass enhancement

3 cm. Lower outer Quadrant. 8:00 Radian. 2 cm from the nipple

Non mass enhancement: Distribution: Linear, Internal enhancement: Clumped, Kinetics: Cannot assess

BI-RADS:4: Suspicious abnormality – Biopsy should be considered

Associated findings RIGHT breast: ☐Nipple retraction, ☐Nipple involvement, ☐Skin retraction, ☐Skin thickening, ☐Skin invasion-direct, ☐Skin invasion-inflammatory, ☒Pectoral muscle invasion, ☒Chest wall invasion, ☐ Architectural distortion

Non-enhancing findings RIGHT breast: X NONE ☐High ductal signal pre contrast T1, ☐Cyst(s), ☐Hematoma/seroma, ☐Post therapy skin/trabecular thickening,
☐Non-enhancing mass, ☐Architectural distortion, ☐Signal void from clips

Fat containing lesions RIGHT: ☐Fat necrosis, ☐Hamartoma, ☐Post-operative
seroma/hematoma with fat

Lymph nodes RIGHT: ☒Normal axillary, ☐Abnormal axillary, ☐ Abnormal internal mammary

Extramammary findings: None

SUMMARY: 1.5 cm mass with findings suspicious for local chest wall invasion and suspected DCIS extending 3 cm towards the nipple

LEFT BI-RADS:2: Benign
RIGHT BI-RADS:5: Highly suggestive of malignancy – Appropriate action should be taken

RECOMMENDATIONS: Oncological/surgical referral. Consideration of MRI guided biopsy of Lesion 2 if it will affect management

Case Discussion

Faculty

Petra J Lewis, MBBS

Professor of Radiology and OBGYN

Dartmouth-Hitchcock Medical Center & Geisel School of Medicine at Dartmouth

Sheryl G. Jordan, MD

Professor, Department of Radiology

University of North Carolina School of Medicine

Ryan W. Woods, MD, MPH

Assistant Professor of Radiology

University of Wisconsin School of Medicine and Public Health

Tags

Women's Health

MRI

Breast

© 2024 Medality. All Rights Reserved.

Contact UsTerms of UsePrivacy Policy